Gabapen



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 36.4%
Pain 18.3%
Convulsion 5.1%
Partial Seizures 5.1%
Cancer Pain 4.4%
Insomnia 4.1%
Neuralgia 3.8%
Post Herpetic Neuralgia 3.1%
Depression 2.5%
Fibromyalgia 2.1%
Pain In Extremity 2.1%
Temporal Lobe Epilepsy 2.1%
Hypoaesthesia 1.8%
Hypertension 1.6%
Analgesic Therapy 1.5%
Trigeminal Neuralgia 1.5%
Complex Partial Seizures 1.2%
Constipation 1.2%
Diabetes Mellitus 1.0%
Intractable Epilepsy 1.0%
Somnolence 25.0%
Epilepsy 8.9%
Weight Increased 7.8%
Renal Impairment 5.2%
Status Epilepticus 5.2%
Urine Output Decreased 5.2%
Convulsion 4.7%
Depressed Level Of Consciousness 4.2%
White Blood Cell Count Decreased 3.6%
Pain 3.1%
Urinary Incontinence 3.1%
Visual Acuity Reduced 3.1%
Blood Creatine Phosphokinase Increased 2.6%
Death 2.6%
Drug Eruption 2.6%
Gamma-glutamyltransferase Increased 2.6%
Hyperkalaemia 2.6%
Interstitial Lung Disease 2.6%
Pyrexia 2.6%
Withdrawal Syndrome 2.6%
Secondary
Pain 34.4%
Epilepsy 11.6%
Hyperlipidaemia 5.0%
Insomnia 4.5%
Partial Seizures 4.5%
Headache 4.3%
Diarrhoea 3.5%
Drug Use For Unknown Indication 3.5%
Hernia Pain 3.3%
Neuralgia 3.3%
Abdominal Hernia 3.0%
Hypertension 3.0%
Ulcer 3.0%
Constipation 2.8%
Back Pain 2.0%
Post Herpetic Neuralgia 2.0%
Encephalitis 1.8%
Benign Prostatic Hyperplasia 1.5%
Depression 1.5%
Herpes Zoster 1.5%
Somnolence 27.2%
Neoplasm Progression 8.6%
White Blood Cell Count Increased 7.4%
Convulsion 6.2%
Overdose 6.2%
Renal Impairment 4.9%
Vision Blurred 4.9%
Iron Deficiency Anaemia 3.7%
Pruritus 3.7%
Cardiac Failure 2.5%
Epilepsy 2.5%
Postrenal Failure 2.5%
Stomatitis Necrotising 2.5%
Tachycardia 2.5%
Thrombocytopenia 2.5%
Tinnitus 2.5%
Toxicity To Various Agents 2.5%
Urine Output Decreased 2.5%
Weight Decreased 2.5%
Withdrawal Syndrome 2.5%
Concomitant
Pain 17.3%
Prophylaxis 16.0%
Cancer Pain 8.7%
Epilepsy 8.0%
Drug Use For Unknown Indication 5.2%
Constipation 5.0%
Analgesic Therapy 4.9%
Multiple Myeloma 4.6%
Product Used For Unknown Indication 3.3%
Lennox-gastaut Syndrome 3.2%
Hypertension 3.1%
Complex Partial Seizures 2.9%
Simple Partial Seizures 2.9%
Plasma Cell Myeloma 2.7%
Delirium 2.6%
Hepatic Neoplasm Malignant 2.1%
Insomnia 1.9%
Partial Seizures With Secondary Generalisation 1.9%
Pneumonia Aspiration 1.9%
Nausea 1.8%
Wrong Technique In Drug Usage Process 13.2%
Tumour Lysis Syndrome 11.2%
Status Epilepticus 10.5%
Epilepsy 6.6%
Thrombocytopenia 5.9%
Interstitial Lung Disease 5.3%
White Blood Cell Count Decreased 5.3%
Palmar-plantar Erythrodysaesthesia Syndrome 3.9%
Platelet Count Decreased 3.9%
Pyrexia 3.9%
Somnolence 3.9%
Pancreatitis Acute 3.3%
Pneumonia 3.3%
Rash 3.3%
Vomiting 3.3%
Altered State Of Consciousness 2.6%
Convulsion 2.6%
Drug Prescribing Error 2.6%
Liver Disorder 2.6%
Pain 2.6%
Interacting
Fibromyalgia 27.8%
Prophylaxis 16.7%
Atrial Fibrillation 11.1%
Cancer Pain 11.1%
Hypertension 11.1%
Multiple Myeloma 11.1%
Pain 11.1%
Somnolence 50.0%
Rash 25.0%
Thrombocytopenia 25.0%